Patients Beyond weight loss: Exploring the impact of weight loss medi... It’s been less than two years since weight loss medications Wegovy and Mounjaro were approved in the UK to treat obesity.
Digital Highlighting the disruptors: Innovation for now and tomorrow... On Tuesday 19th March, pharmaphorum headed to King’s Place, London for the 10th annual WIRED Health conference - an event partnered with EY, Boston Scientific, and Lingo this year, which se
Events Partner Content Gut-Brain Axis 2018 On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year's ev
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
